1
|
Pintor AVB, Queiroz LD, Barcelos R, Primo LSG, Maia LC, Alves GG. MTT versus other cell viability assays to evaluate the biocompatibility of root canal filling materials: a systematic review. Int Endod J 2020; 53:1348-1373. [PMID: 32602945 DOI: 10.1111/iej.13353] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2018] [Revised: 06/20/2020] [Accepted: 06/24/2020] [Indexed: 01/16/2023]
Abstract
OBJECTIVES This systematic review aimed to compare the cytotoxicity of root canal filling materials (RCFMs) assessed using tetrazolium salt-based tests (TSBT), including the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay, with those obtained using other cell viability assays. METHODS A search was performed on PubMed, Scopus, Web of Science and OpenGrey up to March 2019, followed by a manual search. According to the Participants, Exposure, Comparator and Outcomes (PECO) criteria, in vitro studies that evaluated the cytotoxic effect of RCFMss on animal and/or human cells through TSBT and at least one other viability assay were compared. The methodological quality of selected papers was assessed using ToxRTool® and SciRAP® . Data were analysed using Wilcoxon's signed-rank test for paired samples and linear weighting kappa. RESULTS A total of 230 non-duplicated records were identified. After applying the eligibility criteria, 55 studies were selected for methodological evaluation, seven were selected by manual searching, 22 were excluded for methodological reasons, and 40 were included. A total of 410 comparisons were performed between TSBT and distinct cell viability tests (DCVT). MTT had moderate concordance with DCVT using human cells (n = 138 samples) (P = 0.507; k = 0.4225) and animal cells (n = 122 samples) (P = 0.124; k = 0.5775). XTT had good concordance using human (n = 110 samples) (P = 0.507; k = 0.6336) and animal cells (n = 12 samples) (P = 0.564; k = 0.6604). MTT, XTT, WST and MTS assays showed moderate concordance with DCVT (n = 410 samples) (P = 0.375; k = 0.5138) and complete agreement in 226 samples. DISCUSSION The included studies had methodological heterogeneity that was minimized by the systematic review methodology. CONCLUSIONS MTT and XTT do not cause over- or underestimation of cell viability during cytotoxicity screening of root canal filling materials, implying that these assays can be considered reliable for this purpose. Nonetheless, the development of protocols for the cytotoxic screening of these materials on 3D tissue-like cultures aiming to improve their predictability in the clinical scenario is suggested.
Collapse
Affiliation(s)
- A V B Pintor
- Department of Pediatric Dentistry and Orthodontics, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
| | - L D Queiroz
- Post-Graduation Program in Science and Biotechnology, Universidade Federal Fluminense, Rio de Janeiro, Brazil
| | - R Barcelos
- Department of Specific Formation, Institute of Health of Nova Friburgo, Universidade Federal Fluminense - Nova Friburgo, Rio de Janeiro, Brazil
| | - L S G Primo
- Department of Pediatric Dentistry and Orthodontics, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
| | - L C Maia
- Department of Pediatric Dentistry and Orthodontics, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
| | - G G Alves
- Department of Molecular and Cellular Biology, Biology Institute, Universidade Federal Fluminense, Rio de Janeiro, Brazil
| |
Collapse
|
2
|
Fonseca DA, Paula AB, Marto CM, Coelho A, Paulo S, Martinho JP, Carrilho E, Ferreira MM. Biocompatibility of Root Canal Sealers: A Systematic Review of In Vitro and In Vivo Studies. MATERIALS 2019; 12:ma12244113. [PMID: 31818038 PMCID: PMC6947586 DOI: 10.3390/ma12244113] [Citation(s) in RCA: 35] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/19/2019] [Revised: 12/04/2019] [Accepted: 12/06/2019] [Indexed: 02/07/2023]
Abstract
(1) Aim: To perform a systematic review of the literature on the biocompatibility of root canal sealers that encompasses the various types of sealers that are commercially available as well as both in vitro and in vivo evidence. (2) Methods: This systematic review has been registered in PROSPERO (ID 140445) and was carried out according to PRISMA guidelines using the following databases: PubMed, Cochrane Library, ClinicalTrials.gov, Science Direct, and Web of Science Core Collection. Studies published between 2000 and 11 June 2019 that evaluated cytotoxicity (cell viability/proliferation) and biocompatibility (tissue response) of root canal sealers were included. (3) Results: From a total of 1249 studies, 73 in vitro and 21 in vivo studies were included. In general, studies suggest that root canal sealers elicit mild to severe toxic effects and that several factors may influence biocompatibility, e.g., material setting condition and time, material concentration, and type of exposure. Bioactive endodontic sealers seem to exhibit a lower toxic potential in vitro. (4) Conclusions: The available evidence shows that root canal sealers exhibit variable toxic potential at the cellular and tissue level. However, the methodological heterogeneity among studies included in this systematic review and the somewhat conflicting results do not allow a conclusion on which type of sealer presents higher biocompatibility. Further research is crucial to achieve a better understanding of the biological effects of root canal sealers.
Collapse
Affiliation(s)
- Diogo Afonso Fonseca
- Institute of Endodontics, Coimbra Institute for Clinical and Biomedical Research (iCBR), CIBB Center for Innovative Biomedicine and Biotechnology, Faculty of Medicine, University of Coimbra, 3000-075 Coimbra, Portugal
- Correspondence: ; Tel.: +351-239-249-151
| | - Anabela Baptista Paula
- Institute of Integrated Clinical Practice, Coimbra Institute for Clinical and Biomedical Research (iCBR), CIBB Center for Innovative Biomedicine and Biotechnology, CIMAGO—Center of Investigation on Environment, Genetics and Oncobiology, CNC.IBILI, Faculty of Medicine, University of Coimbra, 3000-075 Coimbra, Portugal; (A.B.P.); (C.M.M.); (A.C.); (E.C.)
| | - Carlos Miguel Marto
- Institute of Integrated Clinical Practice, Coimbra Institute for Clinical and Biomedical Research (iCBR), CIBB Center for Innovative Biomedicine and Biotechnology, CIMAGO—Center of Investigation on Environment, Genetics and Oncobiology, CNC.IBILI, Faculty of Medicine, University of Coimbra, 3000-075 Coimbra, Portugal; (A.B.P.); (C.M.M.); (A.C.); (E.C.)
- Institute of Experimental Pathology, Faculty of Medicine, University of Coimbra, 3000-075 Coimbra, Portugal
| | - Ana Coelho
- Institute of Integrated Clinical Practice, Coimbra Institute for Clinical and Biomedical Research (iCBR), CIBB Center for Innovative Biomedicine and Biotechnology, CIMAGO—Center of Investigation on Environment, Genetics and Oncobiology, CNC.IBILI, Faculty of Medicine, University of Coimbra, 3000-075 Coimbra, Portugal; (A.B.P.); (C.M.M.); (A.C.); (E.C.)
| | - Siri Paulo
- Institute of Endodontics, Coimbra Institute for Clinical and Biomedical Research (iCBR), CIBB Center for Innovative Biomedicine and Biotechnology, CIMAGO – Center of Investigation on Environment, Genetics and Oncobiology, CNC.IBILI, Faculty of Medicine, University of Coimbra, 3000-075 Coimbra, Portugal; (S.P.); (J.P.M.); (M.M.F.)
| | - José Pedro Martinho
- Institute of Endodontics, Coimbra Institute for Clinical and Biomedical Research (iCBR), CIBB Center for Innovative Biomedicine and Biotechnology, CIMAGO – Center of Investigation on Environment, Genetics and Oncobiology, CNC.IBILI, Faculty of Medicine, University of Coimbra, 3000-075 Coimbra, Portugal; (S.P.); (J.P.M.); (M.M.F.)
| | - Eunice Carrilho
- Institute of Integrated Clinical Practice, Coimbra Institute for Clinical and Biomedical Research (iCBR), CIBB Center for Innovative Biomedicine and Biotechnology, CIMAGO—Center of Investigation on Environment, Genetics and Oncobiology, CNC.IBILI, Faculty of Medicine, University of Coimbra, 3000-075 Coimbra, Portugal; (A.B.P.); (C.M.M.); (A.C.); (E.C.)
| | - Manuel Marques Ferreira
- Institute of Endodontics, Coimbra Institute for Clinical and Biomedical Research (iCBR), CIBB Center for Innovative Biomedicine and Biotechnology, CIMAGO – Center of Investigation on Environment, Genetics and Oncobiology, CNC.IBILI, Faculty of Medicine, University of Coimbra, 3000-075 Coimbra, Portugal; (S.P.); (J.P.M.); (M.M.F.)
| |
Collapse
|